PUMA BIOTECHNOLOGY, INC. Payments for (Proceeds from) Productive Assets
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Payments for (Proceeds from) Productive Assets of $435.00 thousand for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForProceedsFromProductiveAssets · last filed 2015-05-11
- PUMA BIOTECHNOLOGY, INC. payments for (proceeds from) productive assets for the quarter ending 2015-03-31 was $435.00K, a 103.27% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. payments for (proceeds from) productive assets for the quarter ending 2014-12-31 was $546.00K, a 188.89% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. payments for (proceeds from) productive assets for the quarter ending 2014-09-30 was $128.00K, a 58.02% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. payments for (proceeds from) productive assets for the quarter ending 2014-06-30 was $212.00K, a 23.98% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. payments for (proceeds from) productive assets for fiscal 2014 was $1.10M, a 76.28% increase from fiscal 2013.
- PUMA BIOTECHNOLOGY, INC. payments for (proceeds from) productive assets for fiscal 2013 was $624.00K, a 5.58% increase from fiscal 2012.
- PUMA BIOTECHNOLOGY, INC. payments for (proceeds from) productive assets for fiscal 2012 was $591.00K, a 132.68% increase from fiscal 2011.
- PUMA BIOTECHNOLOGY, INC. payments for (proceeds from) productive assets for fiscal 2011 was $254.00K.
| Period end | Payments for (Proceeds from) Productive Assets 3 month | Payments for (Proceeds from) Productive Assets 6 month | Payments for (Proceeds from) Productive Assets 9 month | Payments for (Proceeds from) Productive Assets 9 month as first filed | Payments for (Proceeds from) Productive Assets 12 month | Payments for (Proceeds from) Productive Assets 25 month | Payments for (Proceeds from) Productive Assets 27 month | Payments for (Proceeds from) Productive Assets 30 month | Payments for (Proceeds from) Productive Assets 33 month | Payments for (Proceeds from) Productive Assets 36 month | Payments for (Proceeds from) Productive Assets 39 month | Payments for (Proceeds from) Productive Assets 42 month | Payments for (Proceeds from) Productive Assets 45 month | Payments for (Proceeds from) Productive Assets 48 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-03-31 | $435.00K 10-Q · filed 2015-05-11 | $981.00K derived: sum of 2 quarters · filed 2015-05-11 | $1.11M derived: sum of 3 quarters · filed 2015-05-11 | $1.32M derived: sum of 4 quarters · filed 2015-05-11 | ||||||||||
| 2014-12-31 | $546.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $674.00K derived: sum of 2 quarters · filed 2015-03-02 | $886.00K derived: sum of 3 quarters · filed 2015-03-02 | $1.10M 10-K · filed 2015-03-02 | ||||||||||
| 2014-09-30 | $128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $340.00K derived: sum of 2 quarters · filed 2014-11-10 | $554.00K 10-Q · filed 2014-11-10 | $743.00K derived: sum of 4 quarters · filed 2015-05-11 | $2.02M 10-Q · filed 2014-11-10 | |||||||||
| 2014-06-30 | $212.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $426.00K 10-Q · filed 2014-08-11 | $615.00K derived: sum of 3 quarters · filed 2015-05-11 | $696.00K derived: sum of 4 quarters · filed 2015-05-11 | $1.90M 10-Q · filed 2014-08-11 | |||||||||
| 2014-03-31 | $214.00K 10-Q · filed 2015-05-11 | $403.00K derived: sum of 2 quarters · filed 2015-05-11 | $484.00K derived: sum of 3 quarters · filed 2015-05-11 | $655.00K derived: sum of 4 quarters · filed 2015-05-11 | $1.68M 10-Q · filed 2014-05-12 | |||||||||
| 2013-12-31 | $189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $270.00K derived: sum of 2 quarters · filed 2015-03-02 | $441.00K derived: sum of 3 quarters · filed 2015-03-02 | $624.00K 10-K · filed 2015-03-02 | $1.47M 10-K · filed 2014-03-03 | |||||||||
| 2013-09-30 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $252.00K derived: sum of 2 quarters · filed 2014-11-10 | $435.00K 10-Q · filed 2014-11-10 | $589.00K derived: sum of 4 quarters · filed 2015-03-02 | $1.28M 10-Q · filed 2013-11-12 | |||||||||
| 2013-06-30 | $171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $354.00K 10-Q · filed 2014-08-11 | $508.00K derived: sum of 3 quarters · filed 2015-03-02 | $517.00K derived: sum of 4 quarters · filed 2015-03-02 | $1.20M 10-Q · filed 2013-08-06 | |||||||||
| 2013-03-31 | $183.00K 10-Q · filed 2014-05-12 | $337.00K derived: sum of 2 quarters · filed 2015-03-02 | $346.00K derived: sum of 3 quarters · filed 2015-03-02 | $587.00K derived: sum of 4 quarters · filed 2015-03-02 | $1.03M 10-Q · filed 2013-05-09 | |||||||||
| 2012-12-31 | $154.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $163.00K derived: sum of 2 quarters · filed 2015-03-02 | $404.00K derived: sum of 3 quarters · filed 2015-03-02 | $591.00K 10-K · filed 2015-03-02 | $845.00K 10-K · filed 2013-04-01 | |||||||||
| 2012-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $250.00K derived: sum of 2 quarters · filed 2013-11-12 | $437.00K 10-Q · filed 2013-11-12 | $437.44K 10-Q · filed 2012-11-14 | $687.64K derived: sum of 4 quarters · filed 2014-03-03 | $690.77K 10-Q · filed 2012-11-14 | ||||||||
| 2012-06-30 | $241.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $428.00K 10-Q · filed 2013-08-06 | $678.64K derived: sum of 3 quarters · filed 2014-03-03 | |||||||||||
| 2012-03-31 | $187.00K 10-Q · filed 2013-05-09 | $437.64K derived: sum of 2 quarters · filed 2014-03-03 | ||||||||||||
| 2011-12-31 | $250.64K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $254.00K 10-K · filed 2014-03-03 | ||||||||||||
| 2011-09-30 | $3.36K 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |